NFKB1 and non-small cell lung carcinoma: Depletion of NF-κB RelA utilizing the kinase inhibitor BMS-345541 effectively reduced stemness and EMT markers, self-renewal, and migratory properties of LCSCs [78], suggesting NF-κB as a promising target for CSC depletion in NSCLC (reviewed in [77]).